AC Immune SA Forecast, price target & analysts
AC Immune SA Target price 2025 - Analyst rating & recommendation
AC Immune SA Classifications & Recommendation:
AC Immune SA Price Target
| Target Price | $8.67 |
| Price | $3.38 |
| Potential |
156.51%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target AC Immune SA 2026 .
The average AC Immune SA target price is $8.67.
This is
156.51%
register free of charge
$12.60
272.78%
register free of charge
$7.07
109.17%
register free of charge
|
|
| A rating was issued by 9 analysts: 8 Analysts recommend AC Immune SA to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AC Immune SA stock has an average upside potential 2026 of
156.51%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 33.92 | 5.09 |
| 84.55% | 84.99% | |
| EBITDA Margin | -183.87% | 398.05% |
| 47.07% | 316.48% | |
| Net Margin | -186.44% | -1,909.05% |
| 49.13% | 923.96% |
5 Analysts have issued a sales forecast AC Immune SA 2025 . The average AC Immune SA sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an AC Immune SA EBITDA forecast 2025. The average AC Immune SA EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
5 AC Immune SA Analysts have issued a net profit forecast 2025. The average AC Immune SA net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.63 | -0.97 |
| 21.25% | 53.97% | |
| P/E | negative | |
| EV/Sales | 35.86 |
5 Analysts have issued a AC Immune SA forecast for earnings per share. The average AC Immune SA EPS is
This results in the following potential growth metrics and future valuations:
Current AC Immune SA Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | May 01 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Apr 03 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Mar 14 2025 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 15 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Nov 06 2024 |
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Sep 18 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 08 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
May 01 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Apr 03 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Mar 14 2025 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 15 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Nov 06 2024 |
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Sep 18 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
